Nearly a third of cancer-related deaths are caused by cachexia, a currently incurable metabolic syndrome that involves ...

The cancer cachexia therapeutics market is gaining traction due to the rising global cancer burden and high prevalence of cachexia in advanced-stage ...

JERUSALEM, Aug. 7 (Xinhua) -- Israeli and U.S. researchers have discovered that disrupted brain-liver communication drives severe weight loss, or cachexia, in cancer patients, Israel's Weizmann ...

Nearly a third of cancer-related deaths are caused by cachexia, a currently incurable metabolic syndrome that involves ...

Cachexia – the massive depletion of muscle mass and adipose tissue – is commonly seen in people with cancer and other major illnesses. Also called cancer cachexia or cancer anorexia cachexia ...

DelveInsight's Cancer Cachexia Market Insights report includes a comprehensive understanding of current treatment practices, cancer cachexia emerging drugs, market share of individual therapies ...

Cachexia’s symptoms include weight loss, muscle wasting, loss of tissue and decreased strength. It is present in 50 to 80 per cent of cancer sufferers with solid tumours.

Cachexia can also surface during infections, for instance, by HIV, tuberculosis, malaria, and other parasites. The condition can’t be cured by getting patients to eat or by giving them nutritional ...

"Cachexia is a common condition in cancer patients associated with weight loss, functional decline and, ultimately, poor outcomes," said Dr. Jeffrey Crawford, principal investigator and George ...

Cachexia was linked to a higher risk of death compared to patients without cachexia, which varied in the definitive criteria used (the Fearon 2011 criteria had a lower hazard ratio for OS than the ...

Cachexia is the muscle wasting and weight loss that often accompany cancer's effects. Two potential treatments that may boost muscle strength are in Phase 3 clinical trials.